CLINICAL TRIAL / NCT03709758

Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML

  • Interventional
  • Recruiting
  • NCT03709758

Phase 1b Study of Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve Subjects With Acute Myelogenous Leukemia

This research study is studying the combination of venetoclax and chemotherapy as a possible treatment for acute myelogenous leukemia (AML). The drugs involved in this study are: - Venetoclax - Daunorubicin - Cytarabine